Takeda Shares Drop as Drugmaker Forecasts Loss After Shire Deal

(Bloomberg) -- Takeda Pharmaceutical Co. shares fell the most this year after the Japanese drugmaker forecast a surprise operating loss due to acquisition costs and related charges from its $62 bil...

Bloomberg Quint

Add BloombergQuint App to Home screen.